FDA.reportPublic FDA data

EPOPROSTENOL Pharmacologic Class Indexing

Class set ID
b0fda973-100c-4a76-a418-43e52adee680
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995Gland Pharma Limited202601065
These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995Sun Pharmaceutical Industries, Inc.202504236
These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995Actelion Pharmaceuticals US, Inc. | Patheon Italia S.p.A. | Cayman Pharma s.r.o. | Wasserburger Arzneimittelwerk GmbH | AndersonBrecon Inc.2022112815
These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995Mylan Institutional LLC202205151